X
Welcome to the
Bioven website
Our focus is on cancer. Our novel immunotherapy for the treatment of lung cancer is currently in Phase III trials.

LEARN MORE
News Updates
31 Mar 2017 Resignation of Group CEO
10 Feb 2017 Pathway Targeted Immunotherapy
Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.